2014 ESC/EACTS Guidelines on myocardial revascularization

European Heart Journal - Tập 35 Số 37 - Trang 2541-2619 - 2014
Stephan Windecker, Philippe Kolh, Fernándo Alfonso, Jean‐Philippe Collet, Jochen Cremer, Volkmar Falk, Gerasimos Filippatos, Christian Hamm, Stuart J. Head, Peter Jüni, A. Pieter Kappetein, Adnan Kastrati, Juhani Knuuti, Ulf Landmesser, Günther Laufer, Franz‐Josef Neumann, Dimitrios J. Richter, Patrick Schauerte, Miguel Sousa‐Uva, Giulio G. Stefanini, David P. Taggart, Lucia Torracca, Marco Valgimigli, William Wijns, Adam Witkowski

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1093/eurheartj/eht330

Gruntzig A . Transluminal dilatation of coronary-artery stenosis. Lancet 1978;1((8058):263).

10.1056/NEJMra1210816

Windecker S Stortecky S Stefanini GG da Costa B Rutjes AW di Nisio M Siletta MG Maione A Alfonso F Clemmensen P Collet JP Cremer J Falk F Filippatos G Hamm C Head SJ Kappetein AP Kastrati A Knuuti J Landmesser U Laufer G Neumann FJ Richter D Schauerte P Sousa-Uva M Taggart D Torracca L Valgimigli M Wijns W Witkowski A Kolh P Juni P . Revascularisation vs. Medical Treatment in Patients With Stable Coronary Artery Disease: A Network Meta-Analysis. BMJ 2014. Jun 23;348:g3859.

10.1093/eurheartj/eht059

10.1016/j.jcin.2012.02.013

10.1016/S1010-7940(99)00134-7

10.1016/S0195-668X(02)00801-1

10.1093/ejcts/ezr285

10.1093/ejcts/ezs584

Nashef SA Roques F Sharples LD Nilsson J Smith C Goldstone AR Lockowandt U . EuroSCORE II. Eur J Cardiothorac Surg 2012;41((4):734–744; discussion):744-745.

10.1016/j.athoracsur.2012.02.064

10.1093/ejcts/ezs406

Grant SW Hickey GL Dimarakis I Trivedi U Bryan A Treasure T Cooper G Pagano D Buchan I Bridgewater B . How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23 740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. Heart . 2012;98(21):1568-1572.

Shahian DM O'Brien SM Filardo G Ferraris VA Haan CK Rich JB Normand SL DeLong ER Shewan CM Dokholyan RS Peterson ED Edwards FH Anderson RP ; Society of Thoracic Surgeons Quality Measurement Task F. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3: valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88 1 Suppl). S43–62.

10.1016/j.athoracsur.2009.05.053

10.1016/S0140-6736(13)60141-5

10.1016/j.jtcvs.2010.07.094

10.1161/CIRCINTERVENTIONS.111.961862

10.1016/j.jcmg.2012.09.013

10.1016/j.jacc.2010.02.005

10.1161/CIRCULATIONAHA.108.842393

10.1161/CIRCINTERVENTIONS.110.958389

10.1093/eurheartj/ehs295

10.1016/S0140-6736(13)60108-7

10.1056/NEJMoa1110717

10.1161/CIRCULATIONAHA.111.066902

10.1161/CIRCULATIONAHA.111.066969

Medina A Suarez de Lezo J Pan M . [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol 2006;59((2):183).

Sianos G Morel MA Kappetein AP Morice MC Colombo A Dawkins K van den Brand M Van Dyck N Russell ME Mohr FW Serruys PW . The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1(2):219-227.

Beauchamp T Childress J . Principles of Biomedical Ethics. 4th. New York: Oxford University Press; 1994.

10.1016/j.athoracsur.2012.05.027

10.1016/j.ejcts.2010.08.033

10.1053/euhj.2000.2282

10.1016/j.jtcvs.2013.01.026

OECD. OECD Publishing; 2009. Health at a glance.

10.1016/j.jacc.2012.01.050

10.1016/j.jcin.2009.05.001

Epstein AJ Polsky D Yang F Yang L Groeneveld PW . Coronary revascularization trends in the United States. JAMA 2011 2001–2008;305(17):1769-1776.

10.1161/CIRCULATIONAHA.109.887539

10.1186/1749-8090-1-2

10.1093/icvts/ivr157

10.1186/1749-8090-8-74

10.1016/S0828-282X(06)70936-9

10.1016/j.jcin.2009.01.006

10.1001/jama.2010.1509

10.1093/eurheartj/eht296

10.1093/eurheartj/eht512

10.1016/j.amjcard.2012.10.028

10.1056/NEJMoa0807611

10.1016/j.jacc.2007.01.087

10.1002/ccd.20175

10.1161/CIRCULATIONAHA.113.002740

10.1056/NEJMoa1205361

10.1016/S0735-1097(02)01726-6

10.1016/j.jacc.2007.09.006

10.1016/j.jacc.2008.08.058

10.1056/NEJMoa0806576

10.1016/j.jcin.2009.03.009

Schuijf JD Wijns W Jukema JW Decramer I Atsma DE de Roos A Stokkel MP Dibbets-Schneider P van der Wall EE Bax JJ . A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT vs. myocardial perfusion on SPECT. J Nucl Med 2006;47(11):1749-55.

10.1016/j.jacc.2008.07.031

Neglia D Rovai D Caselli C Kaufmann P Lombardi M Lorenzoni V Marinelli M Nekolla D Pietila M Scholte A Sicari R Teresinska A Zamorano J Underwood R Knuuti J ; For the EVINCI Investigators. Detection of obstructive coronary artery disease by non invasive anatomical and functional imaging. Results of the multicenter European EVINCI study. Circulation 2013.

Elhendy A Shub C McCully RB Mahoney DW Burger KN Pellikka PA . Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. Am J Med 2001;111(1):18-23.

10.1016/j.amjcard.2004.05.016

10.1016/S0735-1097(02)02863-2

10.1161/hc5001.100528

10.1016/j.jacc.2012.07.038

Shaw LJ Hendel R Borges-Neto S Lauer MS Alazraki N Burnette J Krawczynska E Cerqueira M Maddahi J Myoview Multicenter R . Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 2003;44(2):134-139.

10.1016/j.nuclcard.2005.12.004

10.1161/CIRCIMAGING.112.978270

10.1016/j.jacc.2007.06.030

10.1093/eurheartj/ehm617

10.1093/eurheartj/ehs022

10.1161/CIRCULATIONAHA.106.652016

10.1016/j.jacc.2010.06.020

10.1016/S0735-1097(13)60177-1

10.1161/CIRCULATIONAHA.112.120402

10.1161/CIRCULATIONAHA.109.915009

10.1093/eurheartj/ehr232

10.2967/jnumed.112.104687

10.1136/heartjnl-2012-302761

10.1007/s00259-011-1999-2

10.1136/hrt.2009.179531

10.1093/eurheartj/eht108

10.1016/j.ejcts.2010.08.019

10.1093/eurheartj/ehq277

10.1001/jama.2013.281718

10.1161/01.CIR.0000150392.70749.C7

10.1016/S0140-6736(97)07298-X

10.1016/S0140-6736(01)06100-1

10.1056/NEJMoa070829

10.1001/jama.297.18.1985

10.1056/NEJMoa0805796

10.1161/CIRCULATIONAHA.109.911669

10.7326/0003-4819-152-6-201003160-00007

10.1161/CIRCINTERVENTIONS.112.970954

10.1093/eurheartj/ehq500

10.1093/eurheartj/ehi169

10.1161/CIRCULATIONAHA.107.743963

10.1001/jamainternmed.2013.12855

10.1016/j.jacc.2011.02.074

10.1016/j.jacc.2007.03.067

10.1016/0735-1097(96)87733-3

10.1161/CIRCINTERVENTIONS.108.765610

10.1161/CIRCULATIONAHA.112.131961

10.1016/S0140-6736(09)60552-3

10.1016/j.amjmed.2008.07.027

10.1016/S0140-6736(94)91963-1

Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group. Lancet 1982;2(8309):1173-1180.

10.1056/NEJM198411223112102

10.1056/NEJM198403223101204

10.1056/NEJMoa1100356

10.1056/NEJM199907083410202

10.1161/01.CIR.0000087605.09362.0E

10.1056/NEJMoa066139

10.1016/j.jcin.2008.08.002

10.1136/bmj.321.7253.73

10.1161/CIRCULATIONAHA.104.521864

10.1016/j.jacc.2008.05.051

10.1016/S0140-6736(09)60319-6

10.1161/CIRCULATIONAHA.111.071811

10.1016/j.ahj.2012.05.018

10.1001/archinternmed.2011.1484

10.1016/S0140-6736(07)61444-5

10.1161/CIRCULATIONAHA.112.097014

10.1016/j.jcin.2013.05.005

10.1016/j.jacc.2011.06.049

10.1093/eurheartj/ehs086

10.1016/S0140-6736(13)61782-1

10.1016/S0140-6736(11)61672-3

10.1016/S0140-6736(12)60324-9

10.1136/bmj.f6625

10.1056/NEJMoa1009406

10.1161/CIRCULATIONAHA.112.000646

10.1067/mhj.2001.116072

10.1016/j.athoracsur.2006.04.044

10.1056/NEJMoa071804

10.1161/01.CIR.91.9.2335

10.1161/CIRCULATIONAHA.109.913111

10.1056/NEJM198506273122603

10.1016/S0022-5223(96)70378-1

10.1001/jama.1994.03520190074038

10.1161/01.CIR.0000072790.23090.41

10.1161/01.CIR.95.8.2037

10.1016/j.cjca.2012.07.010

10.1016/0140-6736(93)90348-K

10.1056/NEJM199410203311601

10.1056/NEJM199410203311602

10.1016/S0140-6736(95)92896-0

10.1056/NEJM199607253350401

10.1016/S0735-1097(01)01366-3

10.1016/S0735-1097(00)01052-4

10.1056/NEJM200104123441502

10.1016/S0140-6736(02)11078-6

10.1161/01.CIR.0000100723.50363.2C

10.1161/CIRCULATIONAHA.105.578492

10.1056/NEJMoa0804626

10.1016/j.jacc.2010.09.038

10.1056/NEJMoa1100452

10.1016/j.jcin.2008.07.001

Aziz O Rao C Panesar SS Jones C Morris S Darzi A Athanasiou T . Meta-analysis of minimally invasive internal thoracic artery bypass vs. percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007;334((7594):617).

10.1056/NEJM198601023140101

10.1161/01.CIR.77.4.815

Lytle BW Blackstone EH Sabik JF Houghtaling P Loop FD Cosgrove DM . The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004;78((6):2005–2012; discussion):2012-2014.

10.1016/j.athoracsur.2010.04.006

10.1016/j.jacc.2007.09.067

10.1016/j.jacc.2009.01.035

10.1161/CIRCULATIONAHA.109.899211

10.1161/CIRCULATIONAHA.113.006689

10.1016/j.jacc.2011.07.005

10.1016/j.jacc.2009.07.007

10.1016/j.jacc.2010.03.097

10.1001/jamainternmed.2013.12844

10.7326/0003-4819-147-10-200711200-00185

10.1056/NEJMoa1211585

Head SJ Davierwala PM Serruys PW Redwood SR Colombo A Mack MJ Morice MC Holmes DR Feldman TE Staehle E Underwood P Dawkins KD Kappetein AP Mohr FW . Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J. Published online 21 May 2014; doi:10.1093/eurheartj/ehu213 .

10.1016/j.athoracsur.2012.11.073

10.1016/j.jcin.2012.09.008

10.1016/j.jacc.2009.03.032

10.1093/eurheartj/ehr236

10.1001/jama.293.23.2908

10.1016/j.jacc.2006.06.050

10.1001/jama.300.1.71

10.1016/j.jacc.2010.03.007

10.1093/eurheartj/ehq276

10.7326/0003-4819-158-4-201302190-00006

10.1056/NEJMoa0807986

10.1093/eurheartj/ehm184

10.1016/j.jcin.2010.06.017

10.1016/j.jacc.2011.02.032

10.1016/j.ahj.2007.09.007

10.1161/CIRCINTERVENTIONS.112.974485

10.1161/CIRCULATIONAHA.111.069237

Monteiro P . Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population. Circulation 2006;114 1 Suppl). I467–I472.

10.1016/j.jcin.2010.01.012

Greenhalgh J Hockenhull J Rao N Dundar Y Dickson RC Bagust A . Drug-eluting stents vs. bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst Rev 2010;5:CD004587.

10.1016/S0735-1097(02)01968-X

10.1016/0167-5273(93)90024-B

10.1161/CIRCULATIONAHA.108.826479

10.1016/j.jacc.2004.10.074

10.1093/eurheartj/ehs215

10.1016/S0140-6736(13)61454-3

10.1161/CIRCULATIONAHA.111.033118

10.1001/archinternmed.2011.481

10.1001/jama.2011.862

10.1161/CIR.0b013e3182742cf6

10.1016/S0140-6736(96)02514-7

10.1093/eurheartj/ehi810

10.1016/S0140-6736(06)68148-8

10.1016/S0140-6736(02)09963-4

10.1093/eurheartj/ehp156

10.1001/jama.283.20.2686

10.1161/01.CIR.0000103122.10021.F2

10.1161/CIRCULATIONAHA.111.018549

10.1056/NEJMoa1301092

10.1056/NEJMp1308772

10.1001/jama.284.1.60

10.1093/eurheartj/eht529

10.1056/NEJMoa025142

10.1161/01.CIR.0000091088.63921.8C

10.1056/NEJM199908263410901

10.1161/CIRCULATIONAHA.108.818617

10.1093/eurheartj/ehp113

10.1001/jama.293.23.2865

10.1161/CIRCULATIONAHA.105.586198

10.1161/CIRCULATIONAHA.107.694141

Nallamothu BK Krumholz HM Ko DT LaBresh KA Rathore S Roe MT Schwamm L . Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications. Circulation 2007;116(2). e68–e72.

10.1093/eurheartj/ehp492

Knot J Widimsky P Wijns W Stenestrand U Kristensen SD Van'T Hof A Weidinger F Janzon M Norgaard BL Soerensen JT van de Wetering H Thygesen K Bergsten PA Digerfeldt C Potgieter A Tomer N Fajadet J . How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention 2009;5((3):299):301-309.

10.1056/NEJMsa063117

10.1161/CIRCULATIONAHA.106.638353

10.1136/hrt.2006.101972

10.1016/j.amjcard.2009.04.016

10.1016/j.jacc.2011.02.071

10.1136/hrt.2009.177162

10.1080/14628840310030441

10.1016/S0140-6736(11)60404-2

10.1016/j.jacc.2012.06.017

10.1016/j.jacc.2012.10.032

10.4244/EIJV8I11A192

10.1016/j.amjmed.2003.08.035

10.1056/NEJMoa013404

10.1016/S0140-6736(11)60764-2

10.1093/eurheartj/ehs036

10.1016/j.jacc.2010.05.066

10.1016/j.jacc.2012.01.073

10.1016/S0140-6736(12)61223-9

10.1001/jama.2012.10065

10.1016/j.jcin.2013.07.012

10.1016/S0140-6736(08)60833-8

10.1016/j.jacc.2008.10.017

10.1093/eurheartj/ehn389

10.1016/j.ijcard.2011.11.014

10.1016/j.ijcard.2011.11.102

10.1093/eurheartj/ehn421

10.1056/NEJMoa1308789

10.1016/j.jacc.2006.03.044

10.1016/j.jacc.2010.06.011

10.1001/jama.293.9.1063

10.1016/S0140-6736(09)62001-8

10.1161/CIRCULATIONAHA.113.003653

10.1016/j.jacc.2008.12.055

10.1016/j.jacc.2012.09.004

10.1016/j.jcin.2009.10.017

10.1093/eurheartj/ehq129

10.1016/j.jacc.2011.03.046

10.1056/NEJMoa1305520

10.1016/j.jacc.2013.05.022

10.1093/eurheartj/ehm402

10.1016/j.jcin.2013.04.010

10.1056/NEJMoa0706816

10.1056/NEJMoa0808276

10.1016/S0140-6736(08)60268-8

10.1016/j.jacc.2009.08.007

10.1016/S0140-6736(04)17059-1

10.1016/j.jacc.2005.04.042

10.1016/S0735-1097(03)00763-0

10.1093/eurheartj/ehq204

10.1016/j.jacc.2006.03.064

10.1093/eurheartj/ehq398

10.1136/hrt.2010.193862

10.1056/NEJMoa050849

10.1001/jama.285.2.190

10.1161/01.CIR.90.5.2280

Hillis LD Smith PK Anderson JL Bittl JA Bridges CR Byrne JG Cigarroa JE Disesa VJ Hiratzka LF Hutter AM Jr. Jessen ME Keeley EC Lahey SJ Lange RA London MJ Mack MJ Patel MR Puskas JD Sabik JF Selnes O Shahian DM Trost JC Winniford MD . 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124((23):e652–e735).

Weiss ES Chang DD Joyce DL Nwakanma LU Yuh DD . Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg 2008;135((3):503–11, 511 e1–e3).

McMurray JJ Adamopoulos S Anker SD Auricchio A Bohm M Dickstein K Falk V Filippatos G Fonseca C Gomez-Sanchez MA Jaarsma T Kober L Lip GY Maggioni AP Parkhomenko A Pieske BM Popescu BA Ronnevik PK Rutten FH Schwitter J Seferovic P Stepinska J Trindade PT Voors AA Zannad F Zeiher A . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012 33(14):1787-1847.

10.1016/j.athoracsur.2011.10.064

10.1056/NEJMoa1100358

10.1161/CIRCIMAGING.112.000138

10.1093/eurjhf/hfq020

10.1056/NEJMoa0900559

10.1093/eurheartj/ehs021

Michler RE Rouleau JL Al-Khalidi HR Bonow RO Pellikka PA Pohost GM Holly TA Oh JK Dagenais F Milano C Wrobel K Pirk J Ali IS Jones RH Velazquez EJ Lee KL Di Donato M . Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg 2013;146((5):1139–1145 e6).

Dor V Civaia F Alexandrescu C Sabatier M Montiglio F . Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2011;141((4):905–916, 916 e1–e4).

10.1016/S0195-668X(02)00429-3

10.1016/j.ahj.2009.08.005

10.1016/j.ehj.2003.12.008

10.1016/S0195-668X(02)00844-8

10.1001/jama.1968.03140020041011

10.1056/NEJMoa1208410

10.1016/S0140-6736(13)61783-3

Burkhoff D Cohen H Brunckhorst C O'Neill WW ; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device vs. conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152((3):469 e1–e8).

10.1161/CIRCULATIONAHA.111.040220

10.1093/eurheartj/ehi161

10.1016/j.jacc.2008.05.065

10.1093/eurheartj/ehp292

10.1016/j.healun.2011.12.001

10.1016/j.healun.2012.12.004

10.1016/j.jtcvs.2012.05.058

10.1016/0002-9149(74)90276-8

10.1016/S0735-1097(84)80053-4

10.1016/S0735-1097(02)02048-X

10.1161/01.CIR.82.2.359

10.1016/0002-9149(79)90001-8

10.1016/S0735-1097(03)00120-7

10.1016/S0735-1097(00)00879-2

10.1016/j.amjcard.2006.09.091

10.1016/S0735-1097(98)00344-1

10.1056/NEJM199311253292204

10.1002/(SICI)1097-0304(199710)42:2<151::AID-CCD12>3.0.CO;2-R

10.1016/S0735-1097(01)01796-X

10.1016/S0735-1097(00)00878-0

10.1093/eurheartj/ehn524

10.4244/EIJV8I11A195

10.1161/CIRCINTERVENTIONS.112.972711

10.1016/S0735-1097(00)00845-7

10.1016/0735-1097(92)90315-E

10.1053/euhj.2000.2240

10.1016/j.ejcts.2004.04.027

10.1001/jama.295.21.2511

10.1093/eurheartj/ehn602

10.1111/j.1525-1594.2011.01408.x

10.1056/NEJMoa0805796

10.1007/s12350-012-9548-3

10.1161/CIRCULATIONAHA.112.092973

10.1161/CIRCULATIONAHA.108.791061

10.1016/j.jacc.2012.02.059

10.1161/01.CIR.102.9.1014

10.1016/j.jacc.2007.07.042

10.1056/NEJMoa0904327

10.1016/S0140-6736(06)69416-6

10.1016/j.jacc.2009.11.026

10.1001/jama.2013.279208

Serruys PW Farooq V . Revascularization strategies in patients with diabetes. N Engl J Med 2013;368(15):1454-1455.

10.1093/ejcts/ezt017

10.1016/j.jacc.2009.10.014

10.1016/j.jacc.2012.11.044

10.1016/S2213-8587(13)70089-5

Hakeem A Garg N Bhatti S Rajpurohit N Ahmed Z Uretsky BF . Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc 2013;2(4). e000354.

Stettler C Allemann S Wandel S Kastrati A Morice MC Schomig A Pfisterer ME Stone GW Leon MB de Lezo JS Goy JJ Park SJ Sabate M Suttorp MJ Kelbaek H Spaulding C Menichelli M Vermeersch P Dirksen MT Cervinka P De Carlo M Erglis A Chechi T Ortolani P Schalij MJ Diem P Meier B Windecker S Juni P . Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 2008;337. a1331.

Bangalore S Kumar S Fusaro M Amoroso N Kirtane AJ Byrne RA Williams DO Slater J Cutlip DE Feit F . Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 2012;345. e5170.

10.1093/eurheartj/ehq318

10.1016/j.athoracsur.2012.03.082

10.1161/CIRCULATIONAHA.111.084624

10.1093/ejcts/ezt061

10.1056/NEJMoa0901316

10.1093/eurheartj/ehm518

10.1210/jc.2010-0449

10.1016/j.jcin.2009.04.007

10.1016/j.jtcvs.2010.10.005

10.1056/NEJMoa1307684

10.1001/archinte.167.13.1353

10.1056/NEJM200106213442501

10.1016/j.ehj.2003.10.027

10.1056/NEJM200010193431602

10.1016/j.ahj.2013.04.017

10.1161/CIRCULATIONAHA.112.117606

10.1097/01.ASN.0000135969.33773.0B

10.1016/j.ahj.2006.02.021

10.1161/CIRCULATIONAHA.108.838169

10.1161/01.CIR.0000143629.55725.D9

10.1097/01.ASN.0000083900.92829.F5

10.1016/j.ijcard.2013.06.013

10.1016/j.jacc.2011.06.056

Shenoy C Boura J Orshaw P Harjai KJ . Drug-eluting stents in patients with chronic kidney disease: a prospective registry study. PLoS One 2010;5(11). e15070.

10.1016/j.amjcard.2010.03.037

Charytan DM Li S Liu J Herzog CA . Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation 2012;126 (11 Suppl 1). S164–9.

10.1016/j.ahj.2004.10.010

10.1681/ASN.2012020122

10.1093/ndt/gfq328

10.1681/ASN.2012060554

10.1161/01.CIR.0000129317.12580.68

10.1001/jama.300.9.1038

10.1001/jama.291.19.2328

Li Y Liu Y Fu L Mei C Dai B . Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials. PLoS One 2012;7((4):e34450).

10.1016/j.jacc.2013.07.065

10.7326/0003-4819-150-3-200902030-00006

10.1016/j.jacc.2007.03.058

10.1161/CIRCULATIONAHA.109.865352

10.1016/j.cjca.2011.04.004

10.1093/ejcts/ezs360

10.1016/j.athoracsur.2007.05.016

10.1016/j.amjcard.2007.12.011

10.1016/j.jtcvs.2009.08.042

10.1016/j.jtcvs.2006.09.028

10.1161/CIRCINTERVENTIONS.111.961391

10.1056/NEJMoa021833

10.1016/j.jacc.2006.06.047

10.1161/CIRCULATIONAHA.106.671644

10.1016/j.jacc.2013.04.105

10.1016/j.jacc.2006.02.073

10.1161/CIRCULATIONAHA.111.030759

10.1016/j.jcin.2011.08.017

10.1161/CIRCULATIONAHA.111.038943

10.1093/eurheartj/ehr501

10.1056/NEJMoa023204

10.1016/j.amjmed.2005.08.002

10.1016/j.amjmed.2011.06.029

10.1016/S0002-9343(01)00983-4

10.1093/eurheartj/ehs109

Czer LS Gray RJ Stewart ME De Robertis M Chaux A Matloff JM . Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg 1988;95(3):390-401.

Iung B Drissi MF Michel PL de Pamphilis O Tsezana R Cormier B Vahanian A Acar J . Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. J Heart Valve Dis 1993;2(4):430-439.

Lund O Nielsen TT Pilegaard HK Magnussen K Knudsen MA . The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 1990;100(3):327-337.

10.1016/S0735-1097(87)80161-4

10.1016/j.athoracsur.2006.09.051

10.1016/j.athoracsur.2007.11.074

10.1093/eurheartj/eht381

10.1016/j.jacc.2012.10.049

10.1016/j.ijcard.2013.03.062

Stefanini GG Stortecky S Cao D . Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX-score in patients undergoing transcatheter aortic valve implantation. Eur Heart J 2014. Published online 28 March 2014; doi:1093/eurheartj/ehu074.

10.4244/EIJV7I5A89

10.1016/j.amjcard.2011.09.053

10.1007/s00392-010-0243-6

10.1016/j.jcin.2013.04.015

10.4244/EIJV7I5A90

10.1510/icvts.2011.276360

10.1093/icvts/ivr144

10.1016/j.jacc.2013.01.096

10.1016/j.jcin.2008.07.002

10.1161/CIRCULATIONAHA.111.072256

10.1161/CIRCULATIONAHA.112.143818

10.1016/j.lpm.2009.02.015

10.1212/01.wnl.0000176036.07558.82

10.1001/archneurol.2009.114

10.1001/jama.2011.37

10.1016/j.ahj.2012.10.015

Wardlaw JM Chappell FM Stevenson M De Nigris E Thomas S Gillard J Berry E Young G Rothwell P Roditi G Gough M Brennan A Bamford J Best J . Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006;10((30):iii–iv, ix–x):1-182.

10.1016/j.ejcts.2006.02.001

10.1161/CIRCULATIONAHA.111.083873

10.1056/NEJMoa1200388

10.1016/j.jtcvs.2011.04.031

Misfeld M Brereton RJ Sweetman EA Doig GS . Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: meta-analysis of 11,398 cases from 8 studies. J Thorac Cardiovasc Surg 2011;142((2):e11–e17).

10.1016/j.athoracsur.2010.11.036

Ederle J Featherstone RL Brown MM . Randomized controlled trials comparing endarterectomy and endovascular treatment for carotid artery stenosis: a Cochrane systematic review. Stroke . 2009;40(4):1373-1380.

10.1016/S0140-6736(10)60239-5

10.1056/NEJMoa0912321

Bonati LH Lyrer P Ederle J Featherstone R Brown MM . Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2012;9:CD000515.

10.1016/j.jacc.2013.03.094

10.1001/jama.2011.1357

10.1093/eurheartj/ehr211

10.1016/j.amjcard.2005.04.012

10.1016/j.jcin.2011.09.010

10.1136/bmj.324.7336.S71

10.1007/s00270-005-5288-y

10.1016/j.ejvs.2005.01.012

10.1016/j.amjcard.2010.11.019

10.1161/CIRCULATIONAHA.109.877092

Diehm N Schmidli J Setacci C Ricco JB de Donato G Becker F Robert-Ebadi H Cao P Eckstein HH De Rango P Teraa M Moll FL Dick F Davies AH Lepantalo M Apelqvist J . Chapter III: Management of cardiovascular risk factors and medical therapy. Eur J Vasc Endovasc Surg 2011;42 Suppl 2. S33–42.

10.1056/NEJMoa041905

10.1016/j.jacc.2009.05.041

Fleisher LA Beckman JA Brown KA Calkins H Chaikof EL Fleischmann KE Freeman WK Froehlich JB Kasper EK Kersten JR Riegel B Robb JF . 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009;120(21). e169–e276.

10.1016/j.jacc.2008.10.011

10.1016/j.ejcts.2006.03.062

10.1093/eurheartj/ehs184

Davierwala PM Verevkin A Leontyev S Misfeld M Borger MA Mohr FW . Impact of expeditious management of perioperative myocardial ischemia in patients undergoing isolated coronary artery bypass surgery. Circulation 2013;128 (11 Suppl 1). S226–234.

10.1093/icvts/ivr127

Subramanian S Sabik JF 3rd Houghtaling PL Nowicki ER Blackstone EH Lytle BW . Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. Ann Thorac Surg 2009;87((5):1392–1398; discussion 1400).

10.1056/NEJMoa040982

10.1016/j.jacc.2012.03.037

10.1016/S0003-4975(03)01331-6

10.1161/CIRCULATIONAHA.111.069260

10.1001/jama.294.19.2446

10.1016/j.athoracsur.2011.04.097

10.1161/CIRCULATIONAHA.111.081497

Achouh P Boutekadjirt R Toledano D Hammoudi N Pagny JY Goube P Isselmou KO Lancelin B Fouquet R Acar C . Long-term (5- to 20-year) patency of the radial artery for coronary bypass grafting. J Thorac Cardiovasc Surg 2010;140((1):73–79, 79 e1–e2).

10.1016/j.athoracsur.2005.04.033

10.1016/j.athoracsur.2009.02.006

10.1016/S0735-1097(02)02560-3

10.2459/JCM.0b013e328356a4fc

10.1016/j.jacc.2012.09.045

10.1161/CIRCULATIONAHA.106.651232

10.1161/01.CIR.0000041250.89627.A9

10.1161/01.CIR.0000012783.63093.0C

10.1161/01.CIR.0000080894.51311.0A

10.1016/j.jacc.2007.06.039

10.1016/j.amjcard.2009.12.004

10.1016/j.carrev.2012.01.004

10.1016/j.ahj.2012.04.012

10.1016/j.jcin.2010.08.019

Brilakis ES Lichtenwalter C Abdel-karim AR de Lemos JA Obel O Addo T Roesle M Haagen D Rangan BV Saeed B Bissett JK Sachdeva R Voudris VV Karyofillis P Kar B Rossen J Fasseas P Berger P Banerjee S . Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC Cardiovasc Interv 2011;4(2):176-182.

10.1002/ccd.22720

10.1111/j.1540-8183.2010.00620.x

10.1016/j.jcin.2011.06.009

10.1016/S0140-6736(11)61255-5

10.1002/ccd.23145

10.1002/clc.21984

10.1016/j.jcin.2010.04.012

10.1161/01.CIR.0000036595.92742.69

10.1136/bmj.300.6721.355

10.1001/jama.293.2.165

10.1016/j.jacc.2010.02.009

10.1016/j.jacc.2005.10.078

10.1016/S0735-1097(03)00852-0

10.1016/j.jacc.2006.10.049

10.1016/j.jcin.2012.01.008

10.1056/NEJMoa061254

10.1161/CIRCULATIONAHA.108.839282

10.1016/j.jacc.2012.01.015

10.1016/j.jcin.2010.10.012

10.1016/S0140-6736(12)61964-3

Indermuehle A Bahl R Lansky AJ Froehlich GM Knapp G Timmis A Meier P . Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart . 2013;99(5):327-333.

10.4244/EIJV4I5A99

10.1016/j.jacc.2011.11.024

10.1016/j.jacc.2008.01.070

Alfonso F Dutary J Paulo M Gonzalo N Perez-Vizcayno MJ Jimenez-Quevedo P Escaned J Banuelos C Hernandez R Macaya C . Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart . 2012;98(16):1213-1220.

Armstrong EJ Feldman DN Wang TY Kaltenbach LA Yeo KK Wong SC Spertus J Shaw RE Minutello RM Moussa I Ho KK Rogers JH Shunk KA . Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv 2012;5(2):131-140.

10.1056/NEJMoa0706482

10.1056/NEJMoa0909475

Bonatti JO Zimrin D Lehr EJ Vesely M Kon ZN Wehman B de Biasi AR Hofauer B Weidinger F Schachner T Bonaros N Friedrich G . Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results. Ann Thorac Surg 2012;94((6):1920–1926; discussion 1926).

10.1016/j.jacc.2013.04.007

10.1016/j.jtcvs.2013.10.019

Zembala M Tajstra M Filipiak K Knapik P Hrapkowicz T Gierlotka M Hawranek M Polonski L Gasior M . Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in Multi-vessel coronary artery DisEaSe (POLMIDES) - study design. Kardiol Pol 2011;69(5):460-466.

10.1016/j.jacc.2013.12.006

10.1161/01.CIR.73.6.1254

10.1161/hc3801.096335

10.1056/NEJM199711273372201

10.1111/j.1540-8167.2011.02096.x

10.1111/j.1540-8167.2008.01191.x

10.1093/eurheartj/ehn529

10.1093/eurheartj/ehq105

10.1016/j.hrthm.2007.07.013

10.1056/NEJM199706053362302

Kern KB . Optimal treatment of patients surviving out-of-hospital cardiac arrest. JACC Cardiovasc Interv 2012;5(6):597-605.

10.1161/CIRCULATIONAHA.106.657619

10.1016/j.amjcard.2011.04.008

10.1016/j.ahj.2008.09.016

10.1161/CIRCINTERVENTIONS.109.913665

Cronier P Vignon P Bouferrache K Aegerter P Charron C Templier F Castro S El Mahmoud R Lory C Pichon N Dubourg O Vieillard-Baron A . Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation. Crit Care 2011;15(3). R122.

10.4244/EIJV10I1A7

10.1097/MCA.0b013e32834df552

10.1093/eurheartj/ehp213

10.1016/j.amjcard.2011.10.004

10.4244/EIJV8I9A163

10.1160/TH13-04-0351

10.1161/CIRCINTERVENTIONS.112.968792

10.1093/eurheartj/ehs253

10.1016/j.jtcvs.2010.03.011

10.1093/europace/eur208

10.1161/CIRCULATIONAHA.108.777789

10.1093/eurheartj/ehl272

10.1161/01.CIR.0000021113.44111.3E

10.1067/mhj.2003.147

Lucio EA Flores A Blacher C Leyes PE Lucchese FA Ribeiro JP . Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arq Bras Cardiol 2003;82:42-46.

Tsuboi J Kawazoe K Izumoto H Okabayashi H . Postoperative treatment with carvedilol, a-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. Circ J 2008;72:588-591.

10.1186/1749-8090-5-121

10.1016/j.ejcts.2006.09.003

10.1378/chest.121.4.1203

10.1111/j.1445-5994.2012.02844.x

10.1016/j.jacc.2009.10.058

Kirchhof P Bax J Blomstrom-Lundquist C Calkins H Camm AJ Cappato R Cosio F Crijns H Diener HC Goette A Israel CW Kuck KH Lip GY Nattel S Page RL Ravens U Schotten U Steinbeck G Vardas P Waldo A Wegscheider K Willems S Breithardt G . Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009;30(24). 2969–2977c.

10.1016/S0022-5223(99)70052-8

10.1016/S0735-1097(03)00954-9

10.1016/S0140-6736(09)61343-X

10.1016/j.athoracsur.2006.06.032

10.1161/CIRCULATIONAHA.110.976449

10.1080/14017430600746268

10.1016/j.jacc.2005.12.048

Wang G Bainbridge D Martin J Cheng D . The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg . 2009;109(2):320-30.

10.1093/bja/aen377

10.1016/j.athoracsur.2012.04.005

10.1093/ejcts/ezr242

10.1001/jama.2010.1446

10.1016/j.jtcvs.2010.10.004

10.1056/NEJMoa0900708

Deppe AC Liakopoulos OJ Choi YH Slottosch I Kuhn EW Scherner M Stange S Wahlers T . Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. J Surg Res 2012;180(1):114-124.

10.1016/j.jtcvs.2004.08.054

10.1016/j.athoracsur.2009.09.061

10.1001/jama.2012.8363

10.1016/j.jtcvs.2007.07.042

10.1016/j.athoracsur.2011.10.035

10.1016/j.athoracsur.2008.08.049

Navia JL Olivares G Ehasz P Gillinov AM Svensson LG Brozzi N Lytle B . Endoscopic radial artery harvesting procedure for coronary artery bypass grafting. Ann Cardiothorac Surg 2013;2(4):557-564.

10.1016/S0003-4975(02)03425-2

10.1016/j.ejcts.2010.02.007

10.1016/j.athoracsur.2012.11.068

10.1093/icvts/ivt012

10.1093/icvts/ivt089

10.1067/mtc.2001.111654

10.1016/S0022-5223(99)70053-X

10.1093/ejcts/ezr298

10.1016/j.ijcard.2013.05.004

10.1161/CIRCULATIONAHA.106.614420

10.1016/j.jacc.2012.10.017

10.1093/ejcts/ezr105

10.1161/CIRCULATIONAHA.110.005041

10.1016/j.athoracsur.2012.02.033

10.1016/j.jss.2013.05.042

Rastan AJ Walther T Falk V Kempfert J Merk D Lehmann S Holzhey D Mohr FW . Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 2009;120 (11 Suppl). S70–77.

10.1016/j.jacc.2013.05.033

10.1067/mtc.2000.107280

Boylan MJ Lytle BW Loop FD Taylor PC Borsh JA Goormastic M Cosgrove DM . Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg 1994;107:657-662.

10.1016/j.jtcvs.2005.05.024

10.1097/HCO.0b013e32833f0498

10.1016/S0140-6736(01)06069-X

10.1161/CIRCULATIONAHA.111.030536

Galbut DL Kurlansky PA Traad EA Dorman MJ Zucker M Ebra G . Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up. J Thorac Cardiovasc Surg 2012;143((4):844–853 e4).

10.1093/ejcts/ezr213

Lytle BW . Bilateral internal thoracic artery grafting. Ann Cardiothorac Surg 2013;2(4):485-492.

Weiss AJ Zhao S Tian DH Taggart DP Yan TD . A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting. Ann Cardiothorac Surg 2013;2(4):390-400.

10.1016/j.jtcvs.2012.04.024

10.1186/1745-6215-7-7

10.1111/j.1540-8191.2011.01325.x

10.1510/icvts.2007.164343

10.1016/j.athoracsur.2010.05.038

Tranbaugh RF Dimitrova KR Friedmann P Geller CM Harris LJ Stelzer P Cohen BM Ko W DeCastro H Lucido D Hoffman DM . Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention. Circulation 2012;126 (11 Suppl 1). S170–175.

10.1016/j.athoracsur.2012.05.029

10.1016/j.jtcvs.2009.09.043

10.1016/j.ejcts.2010.01.026

10.1016/j.ejcts.2010.10.006

10.1056/NEJMoa1301228

10.1056/NEJMoa1211666

10.1056/NEJMoa0902905

10.1161/CIRCULATIONAHA.111.052571

10.1161/CIRCULATIONAHA.111.069260

10.1161/01.STR.0000245081.52877.f2

Keeling WB Kilgo PD Puskas JD Halkos ME Lattouf OM Guyton RA Thourani VH . Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index. J Thorac Cardiovasc Surg 2012;146(6):1142-1148.

Puskas JD Williams WH O'Donnell R Patterson RE Sigman SR Smith AS Baio KT Kilgo PD Guyton RA . Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: long-term follow-up of a randomized trial. Ann Thorac Surg 2011;91((6):1836–1842; discussion):1842-1843.

10.1016/j.athoracsur.2009.04.135

10.1093/eurheartj/eht284

Diegeler A Walther T Metz S Falk V Krakor R Autschbach R Mohr FW . Comparison of MIDCAP vs. conventional CABG surgery regarding pain and quality of life. Heart Surg Forum 1999;2((4):290–295; discussion):295-296.

10.1016/S0003-4975(99)00949-2

10.1016/j.ejcts.2011.01.066

10.1093/ejcts/ezt119

10.1001/jama.291.2.195

10.1016/S1010-7940(97)00134-6

10.1001/jama.2012.8363

10.1016/j.jss.2012.12.050

10.1097/HCO.0b013e32833f0498

10.1161/CIRCULATIONAHA.112.117606

Kieser TM Lewin AM Graham MM Martin BJ Galbraith PD Rabi DM Norris CM Faris PD Knudtson ML Ghali WA ; Investigators A. Outcomes associated with bilateral internal thoracic artery grafting: the importance of age. Ann Thorac Surg 2011;92((4):1269–1275; discussion):1275-1276.

10.1056/NEJMoa040982

Tatoulis J . Total arterial coronary revascularization-patient selection, stenoses, conduits, targets. Ann Cardiothorac Surg 2013;2(4):499-506.

Borgermann J Hakim K Renner A Parsa A Aboud A Becker T Masshoff M Zittermann A Gummert JF Kuss O . Clampless off-pump vs. conventional coronary artery revascularization: a propensity score analysis of 788 patients. Circulation 2012;126 (11 Suppl 1). S176–182.

10.7326/0003-4819-138-10-200305200-00005

10.1161/01.CIR.103.23.2816

10.1016/S0735-1097(03)00119-0

10.1016/S0140-6736(13)61720-1

10.1056/NEJMoa067484

10.1056/NEJMoa067193

10.1016/S0140-6736(07)60314-6

10.1001/archinternmed.2012.758

10.1056/NEJMra1112570

10.1056/NEJMoa0910496

10.1056/NEJMoa1004130

10.1016/S0140-6736(12)61962-X

10.1093/eurheartj/ehp352

10.1016/S0140-6736(12)61852-2

10.1161/CIRCULATIONAHA.111.026732

10.1161/CIRCINTERVENTIONS.109.877522

10.1016/j.jcin.2011.06.018

Park KW Kang SH Velders MA Shin DH Hahn S Lim WH Yang HM Lee HY Van Boven AJ Hofma SH Kang HJ Koo BK Oh BH Park YB Kandzari DE Kim HS . Safety and efficacy of everolimus- vs. sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J 2013;165(2). 241–250 e4.

10.1001/jama.2013.278787

10.1016/j.jacc.2011.02.016

von Birgelen C Sen H Lam MK Danse PW Jessurun GA Hautvast RW van Houwelingen GK Schramm AR Gin RM Louwerenburg JW de Man FH Stoel MG Lowik MM Linssen GC Said SA Nienhuis MB Verhorst PM Basalus MW Doggen CJ Tandjung K . Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. Lancet 2013;383(9915):413-423.

10.1016/j.jacc.2012.01.008

10.1016/S0140-6736(09)62127-9

10.1016/S0140-6736(08)61244-1

10.1016/j.jacc.2013.04.045

10.4244/EIJV6I2A32

10.4244/EIJV7I5A94

10.1016/j.jacc.2008.12.012

10.4244/EIJV9I5A93

10.4244/EIJV9I4A79

10.1016/j.jcin.2012.10.018

Vranckx P Serruys PW Gambhir S Sousa E Abizaid A Lemos P Ribeiro E Dani SI Dalal JJ Mehan V Dhar A Dutta AL Reddy KN Chand R Ray A Symons J . Biodegradable-polymer-based, paclitaxel-eluting Infinnium stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study. EuroIntervention 2006;2(3):310-317.

10.1016/j.jcin.2013.05.013

10.4244/EIJV4I1A11

10.1016/j.ihj.2012.07.011

10.1016/j.jacc.2011.12.016

10.1016/j.jacc.2011.12.009

10.1161/CIRCULATIONAHA.105.575977

10.1016/j.jcin.2008.11.015

10.1038/nrcardio.2013.13

10.1016/S0140-6736(08)60415-8

10.1016/S0140-6736(09)60325-1

10.1016/S0140-6736(12)61765-6

Verheye S Ormiston JA Stewart J Webster M Sanidas E Costa R Costa JR Jr. Chamie D Abizaid AS Pinto I Morrison L Toyloy S Bhat V Yan J Abizaid A . A Next-Generation Bioresorbable Coronary Scaffold System-From Bench to First Clinical Evaluation: Six- and 12-Month Clinical and Multimodality Imaging Results. JACC Cardiovasc Interv 2013;7(1):89-99.

10.1007/s00392-008-0664-7

10.4244/EIJV8I4A71

10.1016/j.jacc.2012.02.027

10.1016/j.jacc.2012.09.020

10.4244/EIJV8I4A70

10.4244/EIJV7I6A113

10.4244/EIJV9I5A98

10.4244/EIJV7I6A114

Hehrlein C Dietz U Kubica J Jorgensen E Hoffmann E Naber C Lesiak M Schneider H Wiemer M Tolg R Richardt G . Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Cardiovasc Revasc Med 2012;13(5):260-264.

10.1016/j.jcin.2012.07.017

10.1016/S0735-1097(01)01175-5

10.1056/NEJMoa042000

Mintz GS Garcia-Garcia HM Nicholls SJ Weissman NJ Bruining N Crowe T Tardif JC Serruys PW . Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 2011;6((9):1123–1130, 9).

10.1002/ccd.10537

10.1016/j.amjcard.2010.09.030

10.4244/EIJV8I7A129

10.1161/CIRCINTERVENTIONS.108.799494

10.1161/CIRCULATIONAHA.113.003942

10.1016/j.jacc.2011.09.079

10.1093/eurheartj/eht236

10.1093/eurheartj/ehs095

Radu MD Raber L Heo J Gogas BD Jorgensen E Kelbaek H Muramatsu T Farooq V Helqvist S Garcia-Garcia HM Windecker S Saunamaki K Serruys PW . Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. EuroIntervention 2014;9(9):1085-1094.

10.4244/EIJV8I7A125

10.1161/CIRCULATIONAHA.110.988436

10.1056/NEJM199606273342604

10.1016/j.jacc.2011.11.003

10.1161/CIRCIMAGING.113.000297

10.1016/j.jacc.2011.06.066

10.1016/j.amjcard.2011.11.022

10.1016/0735-1097(92)90631-V

10.1161/CIRCULATIONAHA.106.664920

10.1016/j.jcin.2007.12.008

10.1016/S0002-9149(01)01482-5

Stinis CT Hu SP Price MJ Teirstein PS . Three-year outcome of drug-eluting stent implantation for coronary artery bifurcation lesions. Catheter Cardiovasc Interv 2010;75(3):309-314.

10.1001/jama.293.17.2126

10.1161/01.CIR.0000118474.71662.E3

10.1016/j.jacc.2005.05.080

10.1016/j.jacc.2013.04.015

10.1016/j.ahj.2009.11.032

10.1161/CIRCULATIONAHA.109.888297

10.1161/CIRCINTERVENTIONS.110.958512

10.1016/j.jacc.2010.10.023

10.1002/ccd.23180

10.1016/j.jcin.2012.07.010

10.1161/CIRCULATIONAHA.110.966879

Gwon HC Hahn JY Koo BK Song YB Choi SH Choi JH Lee SH Jeong MH Kim HS Seong IW Yang JY Rha SW Jang Y Yoon JH Tahk SJ Seung KB Park SJ . Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry. Heart . 2012;98(3):225-231.

10.4244/EIJV8I8A147

10.1016/j.jacc.2012.01.085

10.4244/EIJV8I7A123

Di Mario C Werner GS Sianos G Galassi AR Buttner J Dudek D Chevalier B Lefevre T Schofer J Koolen J Sievert H Reimers B Fajadet J Colombo A Gershlick A Serruys PW Reifart N . European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention 2007;3(1):30-43.

10.1016/j.amjcard.2004.12.065

10.1016/j.amjcard.2011.05.021

10.1016/j.jcin.2011.03.021

10.1016/j.jcin.2012.01.012

10.1016/j.ahj.2010.04.015

10.1161/CIRCULATIONAHA.106.612267

10.1161/CIRCOUTCOMES.108.825760

10.4244/EIJV6I3A60

10.1016/j.jacc.2011.12.007

10.1016/j.jcin.2009.10.029

Surmely JF Tsuchikane E Katoh O Nishida Y Nakayama M Nakamura S Oida A Hattori E Suzuki T . New concept for CTO recanalization using controlled antegrade and retrograde subintimal tracking: the CART technique. J Invasive Cardiol 2006;18(7):334-338.

10.4244/EIJV4I1A15

10.1016/j.jacc.2009.12.038

10.1002/ccd.22690

10.4244/EIJV7I10A190

10.1016/j.jcin.2012.05.017

10.4244/EIJV5I4A81

10.1161/01.CIR.52.1.46

10.1016/S0735-1097(86)80217-0

10.1002/ccd.1810120108

10.1136/hrt.37.2.182

10.1016/0002-9149(91)90057-R

Koh JS Koo BK Kim JH Yang HM Park KW Kang HJ Kim HS Oh BH Park YB . Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: major epicardial vessel vs. side branch ostial lesions. JACC Cardiovasc Interv 2012;5(4):409-415.

Muramatsu T Tsukahara R Ho M Ito S Inoue T Akimoto T Hirano K . Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol 1999;11(4):201-206.

Kurbaan AS Kelly PA Sigwart U . Cutting balloon angioplasty and stenting for aorto-ostial lesions. Heart . 1997;77(4):350-352.

10.1253/circj.67.21

10.1016/0002-9149(93)90448-L

Schwartz L Morsi A . The draw-back stent deployment technique: a strategy for the treatment of coronary branch ostial lesions. J Invasive Cardiol 2002;14(2):66-71.

10.1016/j.amjcard.2005.09.057

10.4244/EIJV5I7A134

10.1016/j.amjcard.2006.10.028

10.1016/j.amjcard.2011.06.004

10.1016/j.jacc.2004.05.058

10.1002/ccd.23369

10.1093/eurheartj/ehi138

10.1093/eurheartj/ehr373

10.1056/NEJMra052717

10.1136/bmj.324.7336.S71

10.1001/jama.2012.50788

10.1001/jama.2011.290

10.1161/CIRCULATIONAHA.106.180944

10.1016/j.jacc.2004.03.042

Biondi-Zoccai G Valgimigli M Margheri M Marzocchi A Lettieri C Stabile A Petronio AS Binetti G Bolognese L Bellone P Sardella G Contarini M Sheiban I Marra S Piscione F Romeo F Colombo A Sangiorgi G . Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial. Am Heart J 2012;163((5):835.e1–e7).

10.1056/NEJMoa031859

10.1001/jama.292.6.696

10.1056/NEJMoa0802944

10.1016/j.amjcard.2009.08.668

10.1056/NEJMoa052711

10.1016/j.jcin.2009.08.016

Silvain J Beygui F Barthélémy O Pollack C Jr. Cohen M Zeymer U Huber K Goldstein P Cayla G Collet J-P Vicaut E Montalescot G . Efficacy and safety of enoxaparin vs. unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ 2012;344.

10.1016/j.jacc.2010.01.067

10.1016/j.jacc.2006.04.090

10.1001/jama.288.19.2411

10.1093/eurheartj/ehn169

Collaborative overview of randomised trials of antiplatelet therapy:I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ(Clinical research ed.) 1994;308(6921):81-106.

10.1016/S0140-6736(09)60503-1

10.1161/01.CIR.102.6.624

10.1161/hc3001.093435

10.1161/01.CIR.101.6.590

10.1161/CIRCULATIONAHA.105.559088

10.1161/CIRCULATIONAHA.111.071589

10.1056/NEJM199604253341702

10.1056/NEJM199812033392303

10.1093/eurheartj/ehs318

10.1161/CIRCULATIONAHA.111.059022

Feres F Costa RA Abizaid A Leon MB Marin-Neto JA Botelho RV King SB Negoita M Liu M de Paula JE Mangione JA Meireles GX Castello HJ Nicolela E Perin MA Devito FS Labrunie A Salvadori D Gusmão M Staico R Costa JR de Castro JP Abizaid AS Bhatt DL . Three vs.Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial. JAMA 2013;310(23):2510-2522.

10.1016/j.jacc.2012.06.043

10.1093/eurheartj/ehq330

10.1001/archinte.167.22.2423

10.1093/eurheartj/ehp110

10.1161/CIRCULATIONAHA.108.828541

10.1161/CIRCULATIONAHA.108.857722

10.1056/NEJMoa1205512

10.1016/S0140-6736(10)61088-4

10.1016/S0140-6736(02)07442-1

10.1001/jama.295.13.joc60034

10.1056/NEJMoa062437

10.1001/jama.298.21.2497

10.1056/NEJMoa1109596

10.1016/j.jacc.2009.05.025

10.1016/j.jacc.2006.05.058

10.1001/jama.292.1.45

10.1056/NEJMoa0802944

10.1056/NEJMoa055443

10.1161/CIRCULATIONAHA.109.927582

10.1161/01.CIR.100.15.1593

10.1016/S0140-6736(01)05701-4

10.1056/NEJMoa1308075

10.1001/jama.2010.1320

10.1016/S0140-6736(09)60441-4

10.1016/j.jacc.2012.08.964

10.1016/j.jacc.2010.07.012

10.1093/eurheartj/ehp118

10.1056/NEJM200106213442503

10.1001/jama.290.12.1593

10.1016/j.jcin.2009.06.018

10.1016/S0140-6736(08)61235-0

10.1016/j.jacc.2009.11.091

10.1016/S0140-6736(08)61211-8

10.1001/jama.2012.421

10.1016/S0140-6736(11)61872-2

10.1056/NEJMoa0708191

10.1056/NEJMoa1311096

Shahzad A Kemp I Mars C Wilson K Roome C Cooper R Andron M Appleby C Fisher M Khand A Kunadian B Mills JD Morris JL Morrison WL Munir S Palmer ND Perry RA Ramsdale DR Velavan P Stables RH ; for the HEAT-PPCI trial investigators. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 2014. doi:10.1016/S0140-6736(14)60924-7 .

Richardt G . Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial. Eur Heart J. Published online 9 May 2014; doi:10.1093/eurheartj/ehu182 .

10.1016/j.amjcard.2013.07.003

10.1001/jama.295.13.joc60038

10.1007/s00392-011-0393-1

10.1093/eurheartj/ehr202

10.1093/eurheartj/ehr360

10.1111/j.1538-7836.2011.04513.x

10.1016/S0140-6736(11)60876-3

10.1016/S0735-1097(03)00944-6

10.1056/NEJMoa1300815

10.1016/S0140-6736(13)61615-3

10.1001/jama.2011.2002

10.1056/NEJMoa1112277

10.1016/j.jacc.2013.03.041

10.1016/j.jacc.2013.01.066

10.1056/NEJMoa1105819

10.1093/eurheartj/ehr113

10.1093/eurheartj/ehr334

10.1161/CIRCULATIONAHA.108.832139

10.1016/S0140-6736(09)60738-8

10.1016/j.jacc.2007.11.035

10.1001/archinternmed.2010.271

10.1161/CIRCULATIONAHA.112.114967

10.1161/CIRCINTERVENTIONS.111.965186

10.1093/eurheartj/ehq117

10.1016/j.jacc.2013.02.036

10.1161/CIRCULATIONAHA.112.097014

10.1016/S0140-6736(12)62177-1

10.1056/NEJMoa1001266

10.4244/EIJV8I5A92

Silber S Kirtane AJ Belardi JA Liu M Brar S Rothman M Windecker S . Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. Eur Heart J 2014. published online February 7.

Agewall S Cattaneo M Collet JP Andreotti F Lip GY Verheugt FW Huber K Grove EL Morais J Husted S Wassmann S Rosano G Atar D Pathak A Kjeldsen K Storey RF Pharmacology ESCWGoC Drug T Thrombosis ESCWGo . Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy. Eur Heart J 2013;34((23):1708–1713). 1713a–1713b.

10.1001/jama.294.24.3108

10.1093/eurheartj/ehr204

10.1161/CIRCULATIONAHA.109.933796

10.1093/eurheartj/ehu158

Ferraris VA Saha SP Oestreich JH Song HK Rosengart T Reece TB Mazer CD Bridges CR Despotis GJ Jointer K Clough ER . 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. The Annals of Thoracic Surgery 2012 94(5):1761-1781.

10.1016/j.jacc.2012.03.030

10.1016/j.jacc.2012.07.021

10.1016/j.jacc.2010.03.108

10.1161/CIRCINTERVENTIONS.111.967208

10.1093/bja/aep373

10.1016/S0167-5273(00)00399-5

10.1111/jocs.12074

10.1016/S0140-6736(13)61170-8

10.1001/jama.2011.1332

10.1001/jama.2010.181

10.1093/eurheartj/eht375

10.1016/j.jacc.2012.02.026

10.1056/NEJMoa1209979

10.1016/S0140-6736(08)61845-0

10.1016/S0140-6736(10)61273-1

Mega JL Simon T Anderson JL Bliden K Collet JP Danchin N Giusti B Gurbel P Horne BD Kastrati A Montalescot G Neumann FJ Shen L Sibbing D Steg PG Trenk D Wiviott SD Sabatine MS . CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis. Circulation 2009;120. S598-b-9.

10.1016/j.jacc.2007.12.056

10.1016/S0140-6736(12)60161-5

10.1016/j.amjcard.2004.10.022

10.1016/S0140-6736(96)09457-3

10.1056/NEJMoa1007964

10.1016/S0140-6736(09)61525-7

10.1067/msy.2001.117139

10.1093/eurheartj/ehq151

10.1093/eurheartj/eht161

10.1056/NEJMsa035205

Puskas JD Mack MJ Smith CR . On-pump vs. off-pump CABG. N Engl J Med 2010;362(9):853-854, 851. author reply.

10.1093/eurheartj/ehq172

10.1016/j.athoracsur.2004.12.002

10.1016/j.jtcvs.2011.10.043

10.7326/0003-4819-150-10-200905190-00007

10.1161/CIRCULATIONAHA.104.528455

10.1001/jama.284.24.3139

10.1161/CIRCULATIONAHA.105.578195

10.1093/eurheartj/ehi843

10.1161/hc3901.096668

10.1161/01.CIR.101.15.1806

10.1016/S0735-1097(98)00334-9

10.1056/NEJM200005253422106

10.1136/hrt.2007.118737

10.1161/CIRCULATIONAHA.108.810333

10.1001/jama.2009.1715

Levine GN Bates ER Blankenship JC Bailey SR Bittl JA Cercek B Chambers CE Ellis SG Guyton RA Hollenberg SM Khot UN Lange RA Mauri L Mehran R Moussa ID Mukherjee D Nallamothu BK Ting HH . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58(24). e44–e122.

Di Mario C Di Sciascio G Dubois-Rande JL Michels R Mills P . Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe. EuroIntervention 2006;2(1):31-36.

10.1016/j.jacc.2013.08.1632

10.1093/eurheartj/ehs092

10.1016/S0140-6736(10)61350-5

10.1056/NEJMoa040583

10.1056/NEJMoa050461

10.1056/NEJM199209033271001

10.1056/NEJM199108013250501

10.1056/NEJMoa032292

10.1016/S0140-6736(03)14284-5

10.1056/NEJMoa0801317

10.1056/NEJM200001203420301

10.1016/S0140-6736(03)14286-9

10.1001/jama.290.1.86

10.1161/CIRCULATIONAHA.104.503995

10.1016/j.amjmed.2004.01.009

Taylor RS Unal B Critchley JA Capewell S . Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil 2006;13(3):369-374.

10.1161/CIRCULATIONAHA.109.876383

10.7326/0003-4819-143-9-200511010-00010

Heran BS Chen JM Ebrahim S Moxham T Oldridge N Rees K Thompson DR Taylor RS . Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2011;(7). CD001800.

10.1177/2047487312462824

10.1093/eurheartj/ehr039

10.1016/S0140-6736(04)16980-8

10.1097/HJH.0b013e32832aa6b5

10.1016/S0140-6736(98)04311-6

10.7326/0003-4819-128-12_Part_1-199806150-00001

10.1056/NEJM199309303291401

10.1016/S0140-6736(98)07019-6

10.1016/S0140-6736(98)11181-9

10.1056/NEJM200105313442201

10.1016/S0140-6736(99)04440-2

10.1093/eurheartj/ehi115

10.1056/NEJM199909023411001

10.1056/NEJMoa1009492

10.1056/NEJMoa030207

10.1016/S0140-6736(10)61198-1

10.1093/eurheartj/eht101

10.1093/eurheartj/ehu210

Pilgrim T Heg D Roffi M Tüller D Muller O Vuilliomenet A Cook S Weilenmann D Kaiser C Jamshidi P Fahrni T Moschovitis A Noble S Eberli FR Wenaweser P Jüni P Windecker S . Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary intervention (BIOSCIENCE): a randomised, single-blind, non-inferiority trial. Lancet 2014. doi 10.1016/S0140-6736(14)61038-2.